ALISO VIEJO, Calif., Aug. 2, 2011 /PRNewswire/ —
Avanir Pharmaceuticals, Inc. (NASDAQ:
AVNR) today announced that company management will present an
overview of the company at the following investor conferences in
August.
- Canaccord Genuity Annual Growth Conference
- Location: Intercontinental Hotel, Boston, MA
- Presentation date: Wednesday August 10, 2011
- Presentation time: 10:30am ET
- Wedbush Life Sciences Conference
- Location: Le Parker Meridien, New York, NY
- Presentation date: Tuesday August 16, 2011
- Presentation time: 11:00am ET
A live webcast and 30-day archive of these presentations will be
available at http://www.avanir.com.
About Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. is a biopharmaceutical company
focused on bringing innovative medicines to patients with central
nervous system disorders of high unmet medical need. As part of our
commitment, we have extensively invested in our pipeline and are
dedicated to advancing medicines that can substantially improve the
lives of patients and their loved ones. For more information about
Avanir, please visit www.avanir.com.
AVANIR™ is a trademark owned by Avanir
Pharmaceuticals, Inc.
©2011 Avanir Pharmaceuticals, Inc. All Rights Reserved.
‘/>”/>
SOURCE
